テクニカル掲示板

Chemotherapy is a commonly-used treatment for multiple forms of cancer. However, when cancer cells survive chemotherapy treatment, they can phagocytose, or “eat”, other cells for nutrients and energy. Recently, a team at the University of Tulane was... さらに読む ››

Alzheimer's disease is the most common type of dementia and affects ~55 million people worldwide. Aggregation of tau is a defining feature of Alzheimer’s disease. Recently, researchers at the Indiana University School of Medicine identified Bassoon,... さらに読む ››

Gene therapy is emerging as a promising candidate to treat a wide range of metabolic disorders. Recently, Dr. George Mcilroy and his team at the University of Aberdeen Rowett Institute and Cardiovascular and Diabetes Centre demonstrated the efficacy... さらに読む ››

Pheochromocytoma is a rare tumor that develops in the adrenal glands. To discover novel driver events of the disease, Dr. Patricia Dahia and her team at the University of Texas San Antonio Division of Hematology and Medical Oncology conducted whole... さらに読む ››

One of the major challenges in the clinic for the treatment of various diseases is the ability to consistently deliver therapeutics at efficacious levels. Recently, researchers in the Division of Hematology and Oncology at Nationwide Children’s Hos... さらに読む ››

Stereocilia are important structures found in the inner ear that are involved in hearing and balance. Recently, scientists at the Vollum Institute at the Oregon Health and Science University were able to provide insight into the structure and confo... さらに読む ››

New advances in molecular barcoding offer exciting possibilities, especially in cancer research. Over the years, molecular barcoding involved generating specific nucleic acids or proteins within cells to trace lineages across generations to observe... さらに読む ››

The pandemic COVID-19 has caused over 2 million deaths globally with the numbers increasing at an alarming rate. A monumental worldwide vaccination program is being rolled out with several companies including AstraZeneca/Oxford University, Pfizer/Bi... さらに読む ››

One of the greatest barriers to treating neural degeneration and neural tissue injury is the fact that neurons do not proliferate, and there are only a few areas of the brain that exhibit neurogenesis. It is possible to convert one somatic cell type... さらに読む ››

We have all been engulfed by the current SARS-CoV-2 pandemic with the lives of millions affected. To date, COVID-19 has resulted in almost 8 million confirmed cases with over 400,000 deaths. Considerable effort and money have been invested in trying... さらに読む ››

During the beginning of this year, a novel coronavirus disease — termed Covid-19 by the WHO — was identified as being responsible for a sudden increase in cases of pneumonia in hospitalized patients. We have seen this rapidly escalate into a global... さらに読む ››

The ability to knock in (KI) DNA sequences via homologous recombination (HR) to generate knockout (KO) mice was first demonstrated 30 years ago by Mario R. Capecchi, Martin J. Evans and Oliver Smithies (1,2). In recent years, CRISPR/Cas9 has revolut... さらに読む ››

Cardiovascular diseases (CVDs) are the number one cause of death globally, responsible for 31% of all human mortalities. This is in part due to lifestyle but also because the human heart is incapable of functional regeneration following injury or on... さらに読む ››

Wouldn’t it be nice if we felt no pain? Although lacking the ability to feel pain sounds tempting, considering we could have simply moved on with our lives without going through the hassle of tending to our injuries, the consequences of being painles... さらに読む ››

When the lab of Shinya Yamanaka revealed that viral introduction of Oct3/4, Sox2, Klf4 and c-Myc (OSKM) into adult skin cells could transform them into induced pluripotent stem cells (iPSCs), the world quickly took notice at the prospect of using iP... さらに読む ››